stockportfolio.pro logostockportfolio.pro
Stocks Screener Start 7-day free trial
Stocks / BIO / Gross Profit

Bio-Rad Laboratories, Inc. Gross Profit 2008–2025

Bio-Rad Laboratories, Inc. (BIO) annual gross profit by fiscal year, computed from SEC filings. Compound growth +2.0%/yr over 17 years.

Fiscal yearGross ProfitGross marginChange (YoY)
FY 2025$1.34B51.9%-2.8%
FY 2024$1.38B53.7%-3.4%
FY 2023$1.43B53.4%-9.0%
FY 2022$1.57B55.9%-4.3%
FY 2021$1.64B56.1%+13.9%
FY 2020$1.44B56.5%+14.4%
FY 2019$1.26B54.4%+2.8%
FY 2018$1.22B53.4%+3.0%
FY 2017$1.19B55.0%+4.3%
FY 2016$1.14B55.0%+1.5%
FY 2015$1.12B55.5%-4.8%
FY 2014$1.18B54.2%+0.0%
FY 2013$1.18B55.3%+2.0%
FY 2012$1.16B55.8%-2.0%
FY 2011$1.18B56.9%+8.0%
FY 2010$1.09B56.6%+9.2%
FY 2009$999.84M56.0%+3.9%
FY 2008$962.52M54.6%

Source: Bio-Rad Laboratories, Inc. SEC filings — income statement (10-K). Refreshed nightly.

See the full picture for Bio-Rad Laboratories, Inc.

Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.

Open the interactive view — free

Bio-Rad Laboratories, Inc. — frequently asked questions

What is Bio-Rad Laboratories, Inc.'s gross profit?

Bio-Rad Laboratories, Inc. (BIO) reported gross profit of $1.34B for fiscal year 2025, per its SEC filings.

How has Bio-Rad Laboratories, Inc.'s gross profit changed over time?

Between fiscal 2008 and 2025, BIO's gross profit grew at roughly 2.0% per year (compound annual rate), from $962.52M to $1.34B.

Where does this data come from?

Figures are computed from Bio-Rad Laboratories, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.

More BIO financial history

Full BIO fundamentals page → · All 1,500+ companies →